ArticleDiseases (Basel, Switzerland)2026
Association Between Chronic Kidney Disease and Subclinical Hypothyroidism Categorized by Hypertension Status.
Article in Diseases (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
BACKGROUND/
objectivesSubclinical hypothyroidism (SCH) has been reported to be associated with chronic kidney disease (CKD). Anti-thyroid peroxidase antibody (TPO-Ab) positivity, a known cause of autoimmune thyroid disease, has been reported to be positively associated with SCH with hypertension, but not with SCH without hypertension. Therefore, hypertension status might indicate latent thyroid damage among individuals with SCH. This distinction suggests that categorizing SCH by hypertension status could be useful for evaluating its association with CKD.
methodsA cross-sectional study of 1479 Japanese aged 40-69 years, all of whom had thyroid hormone levels (free triiodothyronine and free thyroxine) within the normal range, was conducted to evaluate the association between CKD and SCH categorized by hypertension status.
resultsNo significant association between SCH without hypertension and CKD was observed. However, a significant positive association between SCH with hypertension and CKD was identified. The potential confounders-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were 0.96 (0.39, 2.38) for SCH without hypertension and 2.76 (1.37, 5.59) for SCH with hypertension.
conclusionsAlthough further investigation is warranted, categorizing SCH by hypertension status may be useful for understanding the association between SCH and CKD. These findings may help clarify the biological significance of SCH in the development of CKD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.